论文部分内容阅读
目的观察热疗对免疫性血小板减少症患者的疗效;方法选择ITP患者50例,随机分成治疗组及对照组,治疗组采用热疗和大剂量地塞米松治疗,对照组仅采用大剂量地塞米松治疗,观察疗效及血小板恢复正常时间及倍增时间。结果总有效率(OR)对照组(88%)与治疗组(92%)之间无统计学差异,完全缓解率(CR)对照组(80%)高于治疗组(52%),两组之间有统计学差异(P<0.05);血小板计数达到正常值的时间,治疗组(9.28±0.96)天,早于对照组(11.56±1.34)天;血小板计数倍增时间治疗组(5.81±0.67)天,早于对照组(7.84±0.89)天,两组比较均存在统计学意义(P<0.05)。结论热疗可缩短ITP患者血小板升到正常值的时间,增加完全缓解率,降低出血风险,值得临床应用。
Objective To observe the effect of hyperthermia on patients with immune thrombocytopenia. Methods Fifty patients with ITP were randomly divided into treatment group and control group. The treatment group was treated with hyperthermia and high-dose dexamethasone, while the control group was treated with high-dose dexamethasone Matson treatment, observation of efficacy and platelet recovery time and doubling time. Results The total effective rate (OR) was not significantly different between the control group (88%) and the treatment group (92%), and the CR rate was higher in the control group (80%) than in the treatment group (52% (9.28 ± 0.96) days, earlier than the control group (11.56 ± 1.34) days; platelet doubling time treatment group (5.81 ± 0.67) (P <0.05); platelet count reached the normal value of the time, ) Day, earlier than the control group (7.84 ± 0.89) days, the two groups were statistically significant (P <0.05). Conclusion Hyperthermia can shorten the platelet ITP patients to normal time, increase the complete remission rate and reduce the risk of bleeding, is worth clinical application.